PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts

Cancer Gene Therapy

Volumn 16, Issue 2, 2009, Pages 161-170

  Parry, J J ^a   Sharma, V ^b   Andrews, R ^a   Moros, E G ^c   Piwnica Worms, D ^b   Rogers, B E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adenovirus; Heat shock promoter; Hyperthermia; PET imaging; Thymidine kinase

Indexed keywords

9 (4 FLUORO 3 HYDROXYMETHYLBUTYL)GUANINE F 18; ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; PENCICLOVIR; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; ISOTOPE LABELING; KIDNEY; LIVER; MOUSE; MOUTH CARCINOMA; MUSCLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SQUAMOUS CELL CARCINOMA; SUICIDE GENE THERAPY; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TUMOR XENOGRAFT;

ACYCLOVIR; ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HEAT-SHOCK PROTEINS; HOT TEMPERATURE; HUMANS; LIVER; MICE; MICE, SCID; POSITRON-EMISSION TOMOGRAPHY; TRANSPLANTATION, HETEROLOGOUS;

ADENOVIRIDAE; HUMAN HERPESVIRUS 1; MUS;

EID: 58349097695     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2008.70     Document Type: Article

References (35)

1. McCormick F. Cancer gene therapy: fringe of cutting edge? Nat Rev Cancer 2001; 1: 130-141.
2. Yamamoto M, Curiel DT. Cancer gene therapy. Technol Cancer Res Treat 2005; 4: 315-330.
3. Rein DT, Breidenbach M, Curiel DT. Current developments in adenovirus-based cancer gene therapy. Future Oncol 2006; 2: 137-143.
4. Siders WM, Halloran PJ, Fenton RG. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus. Cancer Gene Ther 1998; 5: 281-291.
5. Yamamoto M, Alemany R, Adachi Y, Grizzle WE, Curiel DT. Characterization of the cyclooxyygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers. Mol Ther 2001; 3: 385-394.
6. Uchino J, Takayama K, Harada A, Kawakami Y, Inoue H, Curiel DT et al. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment. Cancer Gene Ther 2005; 12: 737-748.
7. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER et al. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Therapy 2005; 12: 272-280.
8. Greco O, Powell TM, Marples B, Joiner MC, Scott SD. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Cancer Gene Ther 2005; 12: 655-662.
9. Yamini B, Yu X, Gillespie GY, Kufe DW, Weichselbaum RR. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. Cancer Res 2004; 64: 6381-6384.
10. Li CY, Dewhirst MW. Hyperthermia-regulated immunogene therapy. Int J Hyperthermia 2002; 18: 586-596.
11. Borrelli MJ, Schoenherr DM, Wong A, Bernock LJ, Corry PM. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res 2001; 61: 1113-1121.
12. Brade AM, Ngo D, Szmitko P, Li PX, Liu FF, Klamut HJ. Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Ther 2000; 7: 1566-1574.
13. Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000; 60: 3435-3439.
14. Li GC, He F, Shao X, Urano M, Shen L, Kim D et al. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res 2003; 63: 3268-3274.
15. Luker GD, Sharma V, Pica CM, Dahlheimer JL, Li W, Ochesky J et al. Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci USA 2002; 99: 6961-6966.
16. Black ME, Newcomb TG, Wilson HM, Loeb LA. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci USA 1996; 93: 3525-3529.
17. Singh AK, Moros E, Novak P, Straube W, Zeug A, Locke JE et al. MicroPET-compatible, small animal hyperthermia ultrasound system (SAHUS) for sustainable, collimated and controlled hyperthermia of subcutaneously implanted tumors. Int J Hyperthermia 2003; 20: 32-44.
18. Novák P, Moros EG, Parry JJ, Rogers BE, Myerson RJ, Zeug A et al. Experience with a small animal hyperthermia ultrasound system (SAHUS): report on 83 tumours. Phys Med Biol 2005; 50: 5127-5139.
19. Luker GD, Sharma V, Piwnica-Worms D. Visualizing protein-protein interactions in living animals. Methods 2003; 29: 110-122.
20. Gross S, Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 2005; 7: 5-15.
21. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002; 13: 1173-1184.
22. Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 6: 479-486.
23. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994; 28: 163-169.
24. Myerson RJ, Straube WL, Moros EG, Emami BN, Lee HK, Perez CA et al. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperthermia 1999; 15: 251-266.
25. Oleson JR, Dewhirst MW, Harrelson JM, Leopold KA, Samulski TV, Tso CY. Tumor temperature distributions predict hyperthermia effect. Int J Radiat Oncol Biol Phys 1989; 16: 559-570.
26. Blackburn RV, Galoforo SS, Corry PM, Lee YJ. Adenoviral-mediated transfer of heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res 1998; 58: 1358-1362.
27. Lee YJ, Galoforo SS, Battle P, Lee H, Corry PM, Jessup JM. Replicating adenoviral vector-mediated transfer of a heat-inducible suicide gene for gene therapy. Cancer Gene Ther 2001; 8: 397-404.
28. Lee YJ, Lee H, Borrelli MJ. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Cancer Gene Ther 2002; 9: 267-274.
29. Lohr F, Hu K, Huang Q, Zhang L, Samulski TV, Dewhirst MW et al. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. Int J Radiat Oncol Biol Phys 2000; 48: 1513-1518.
30. Lohr F, Huang Q, Hu K, Dewhirst MW, Li CY. Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors. Clin Cancer Res 2001; 7: 3625-3628.
31. Siddiqui F, Ehrhart EJ, Charles B, Chubb L, Li CY, Zhang X et al. Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct. Int J Hyperthermia 2006; 22: 587-606.
32. Siddiqui F, Li CY, Larue SM, Poulson JM, Avery PR, Pruitt AF et al. A phase I trial of hyperthermia-induced inter-leukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol Cancer Ther 2007; 6: 380-389.
33. 188Re. J Nucl Med 2000; 41: 887-895.
34. Yaghoubi SS, Gambhir SS. PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]-FHBG. Nat Protoc 2006; 1: 3069-3075.
35. Li GC, He F, Ling CC. Hyperthermia and gene therapy: potential use of microPET imaging. Int J Hyperthermia 2006; 22: 215-221.